- Novavax COVID Vaccine Moves Closer to Full FDA Approval
- Nearly Half of Americans Breathe Unhealthy Air, New Report Finds
- California Gives $25 Gift Cards To Boost Bird Flu Testing
- Four-Gene Combo Might Predict Lethality Of Stomach Cancer
- Blood Test Can Predict Fatty Liver Disease
- These Three Bad Habits Can Harm Your Health As Young As Your Mid-30s
- Umbilical Cord Could Contain Clues For Child’s Future Health
- Colon Cancer Screening Program Cut Cases, Deaths, Eliminated Racial Gaps
- Signs Of Dementia, Alzheimer’s Can Appear Prior To Middle Age
- HHS, FDA Offer Timeline for Phasing Out Petroleum-Based Food Dyes
Antibiotic-Resistant Infections Up Among Hospitalized Kids: Study

SATURDAY, Oct. 26Hospitalized children are developing antibiotic-resistant staph infections of their musculoskeletal systems in rising numbers, resulting in longer hospital stays, more surgeries and other related complications, a new study finds.
The researchers looked at the number of cases of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) musculoskeletal infections at a large U.S. children’s hospital between 2001 and 2010.
“Methicillin-sensitive” means an infection does respond to treatment by the antibiotic.
During the study decade, there were 111 MSSA and 37 MRSA cases. The proportion of MRSA cases rose from 9 percent in 2001 to 29 percent in 2010, a threefold increase. Compared to those with MSSA, kids with MRSA had longer hospital stays (13 days versus 8 days) and were more likely to have multiple surgeries (38 percent versus 15 percent).
Children with the antibiotic-resistant infections were also more likely to have complications such as blood clots, septic shock, recurrent infection and cell death (22 percent versus 6 percent), according to the study presented Saturday at the American Academy of Pediatrics national conference, in Orlando, Fla.
“As MRSA infections rise, prompt recognition and aggressive treatment of MRSA musculoskeletal infections are critical to avoiding life-threatening complications, and improving patient outcomes,” study lead author Eric Sarkissian said in an academy news release.
“Our findings support prior concern about the increased virulence of MRSA compared to MSSA infections,” Sarkissian said. “Optimizing patient outcomes will require increased health-care provider vigilance, early broad-spectrum antibiotic administration and aggressive surgical management.”
Because this study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.
More information
The U.S. National Institute of Allergy and Infectious Diseases has more about MRSA.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.